Yihua R. Huang
No. 56, Lingyuan West Road
Guangzhou, 510055, China
Guangzhou, 510055, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 52 publications
Yeast polysaccharide YE-2-1 promoted ingenol-3-angelate production in Euphorbia peplus cambium meristematic cell cultures.
Journal: International journal of biological macromolecules
Published: March 19, 2026
Retraction notice to "In vitro and in silico anti-osteoporosis activities and underlying mechanisms of a fructan, ABW90-1, from Achyranthes bidentate" [Carbohydr. Polym. 276 (2022) 118730].
Journal: Carbohydrate polymers
Published: December 10, 2025
The Oncogenic EGFR-SHC1 Fusion Confers Insensitivity to EGFR-TKIs via Dual Activation of N-EGFR Kinase Domain and C-SHC1 Phosphorylation Sites in Lung Cancer.
Journal: Cancer discovery
Published: November 01, 2025
FAK activation drives non-genetic adaptive survival of ALK-rearranged lung cancer under tyrosine kinase inhibitor treatment.
Journal: Journal of genetics and genomics = Yi chuan xue bao
Published: October 26, 2025
Association between impacted third molars and external root resorption on adjacent second molars based on cone-beam computed tomography: a systematic review and meta-analysis.
Journal: BMC oral health
Published: October 05, 2025
Comparative analysis of the push-out bond strength of fiber posts: Immediate vs. delayed post-space preparation with two obturation techniques.
Journal: PloS one
Published: July 13, 2025
Activating NEDD4L suppresses EGFR-driven lung adenocarcinoma growth via facilitating EGFR proteasomal degradation.
Journal: Journal of experimental & clinical cancer research : CR
Published: March 23, 2025
Thymosin α1 alleviates pulpitis by inhibiting ferroptosis of dental pulp cells.
Journal: International journal of oral science
Published: December 15, 2024
Onboard measurements of organic vapor emissions from river vessels under various operational conditions.
Journal: Environmental pollution (Barking, Essex : 1987)
Published: September 30, 2024
CCN1 is a therapeutic target upregulated in EML4-ALK mutant lung adenocarcinoma reversibly resistant to alectinib.
Journal: Cell death & disease
Published: September 08, 2024
Rare transformation from lung adenocarcinoma to sarcomatoid carcinoma mediates resistance to inhibitors targeting different driver oncogenes.
Journal: Journal of the National Cancer Center
Published: August 17, 2024
Last Updated: 09/26/2026